The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Wound debridement devices are special devices used to remove dead or unhealthy tissue from a wound to promote healing. GlobalData uses proprietary data and analytics to provide a comprehensive report on the wound debridement devices market in Belgium. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the wound debridement devices market in Belgium was Becton Dickinson and Co followed by Lohmann & Rauscher, Smith & Nephew, Stryker and Zimmer Biomet.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Debridement can be done by various methods, for example autolytic wound debridement devices (which include wet to dry dressings), enzymatic debridement (which are ointments contain enzymatic agents), mechanical debridement, hydrosurgery debridement devices, low frequency ultrasound devices, surgical debridement devices, and maggot therapy. Autolytic wound debridement devices, surgical debridement devices, enzymatic debridement agents and maggot therapy are not tracked under this category.

The wound debridement devices market in Belgium can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size wound debridement devices in Belgium, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.